Brain cancer review promised after Archie Goodburn’s appeal
Ministers have set out four measures intended to speed research, trials and access to promising treatments.
The government has announced an expert review of progress in brain cancer research after meeting campaigner and swimmer Archie Goodburn. Ministers say the review will report within three months and will be followed by a national action plan.
The review will be led by Professor Anthony Chalmers, chair of the Brain Tumour Group within the UK Collaborative for Cancer Clinical Research. It will assess what has changed since the government’s 2018 review of brain tumour research and identify what is still slowing progress for patients.
The government has also promised to appoint a national clinical lead for brain cancer. The Department of Health and Social Care said the post would help drive the work forward, but it has not yet named the appointee or given a start date.
A separate review of the rules for medicines for rare conditions, known as orphan drugs, is being brought forward. The Prime Minister has asked the Medicines and Healthcare products Regulatory Agency to complete it in two years rather than three. The announcement does not guarantee that any particular medicine will be approved or funded.
The measures follow a meeting at Downing Street with Goodburn, a 25-year-old swimmer who has inoperable brain cancer. He appealed for faster progress during an appearance on BBC Breakfast and has campaigned publicly for greater attention to the disease.
The government said the National Institute for Health and Care Research is supporting 59 brain tumour studies, including 35 clinical trials testing new treatments. Those figures describe studies currently supported by the institute; they do not mean that every patient will be eligible for a trial or that a new treatment is ready for routine use.
Patients, families and charities will be asked to help design work to increase participation in clinical trials. The government also plans to work with researchers and industry to make the UK a more attractive place to run trials and says it will partner with Cancer Research UK next year to convene international experts.
The Brain Tumour Research charity said before the meeting that it was a pivotal opportunity to improve research funding, innovation and access to treatments. The government said the new review would share its findings with the All-Party Parliamentary Group on Brain Tumours and brain cancer charities.
The announcement is therefore a programme of reviews, appointments and planning rather than a new treatment policy taking effect immediately. Its success will depend on the evidence collected by the expert review, the action plan that follows and whether the promised changes lead to more trials and faster development without weakening safety standards.
Fact-check Approved · Priya Shah — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The article accurately separates the government’s announced commitments from outcomes that have not yet occurred. The personal background and charity response are supported by BBC and ITV reporting, while the policy details come from the government announcement.
- confirmed The government announced an expert review of brain cancer progress on 14 October 2026. — The government announcement is dated 14 October 2026. source
- confirmed The review will be led by Professor Anthony Chalmers and report within three months. — Both details are stated in the government announcement. source
- confirmed The government intends to appoint a national brain cancer clinical lead. — The appointment is one of the four measures announced; the appointee was not yet named. source
- confirmed The MHRA’s review of orphan-drug rules is being brought forward from three years to two. — This timetable is stated in the government announcement. source
- confirmed The government said 59 brain tumour studies, including 35 clinical trials, are supported by the NIHR. — The figures are given in the government announcement and are attributed to the government. source
- confirmed Archie Goodburn met the Prime Minister after making an appeal on BBC Breakfast. — The government announcement records the meeting and the BBC Breakfast appeal; ITV reported the planned meeting and campaign context on 11 October. source
- confirmed The measures do not guarantee approval or funding of a particular treatment. — The announcement describes reviews and plans, not an approval or funding decision for a named treatment. source
Editor's note
The government’s four measures, review timetable, named review chair and study figures come from the 14 October announcement. The measures are commitments for future work, not evidence that treatments have already accelerated.Sources
- Brain cancer patients to see faster development of new treatments — Prime Minister’s Office and Department of Health and Social Care
- Plea for brain tumour research funding as PM to meet with Archie Goodburn — ITV News
- Archie Goodburn: Commonwealth Games swimmer has brain cancer — BBC Sport
More on this in other media
- ITV News — „brain cancer”
- BBC News — „brain cancer”
- The Guardian — „brain cancer”